Compare · ROP vs TEM
ROP vs TEM
Side-by-side comparison of Roper Technologies Inc. (ROP) and Tempus AI Inc. (TEM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ROP and TEM operate in Computer Software: Programming Data Processing (Technology), so they compete in similar markets.
- ROP is the larger of the two at $45.94B, about 3.7x TEM ($12.40B).
- Both names hit the wire about 11 times in the past 4 weeks.
- Both have 25 recent analyst ratings on file.
- Company
- Roper Technologies Inc.
- Tempus AI Inc.
- Price
- -
- -
- Market cap
- $45.94B
- $12.40B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Computer Software: Programming Data Processing
- Computer Software: Programming Data Processing
- Exchange
- NYSE
- NASDAQ
- IPO
- 1992
- 2024
- News (4w)
- 11
- 11
- Recent ratings
- 25
- 25
Roper Technologies Inc.
Roper Technologies, Inc. designs and develops software, and engineered products and solutions. The company offers management, campus solutions, laboratory information management, enterprise management, information solutions, transportation management, financial and compliance management, cloud-based financial analytics and performance management, and diagnostic and laboratory information system software; and software, services, and technologies for foodservice operations. It also provides cloud-based data, collaboration, and estimating automation software; electronic marketplace; visual effects and 3D content software; wireless sensor network and solutions; cloud-based software solutions; supply chain software; health care service and software; RFID card readers; data analytics and information; pharmacy software; and toll system and products, transaction and violation processing services, and intelligent traffic systems. In addition, the company offers precision rubber and polymer testing instruments, and data analysis software; ultrasound accessories; radiotherapy solutions; testing and analyzing plastic solutions; dispensers and metering pumps; control valves; precision weighing equipment; automated surgical scrub and linen dispensing equipment; water meters; optical and electromagnetic measurement systems; automated leak detection equipment; medical devices; products and services for water and gas utilities; and equipment and consumables. It also provides temperature control and emergency shutoff valves; turbomachinery control hardware, software, and services; specialized pumps; flow meter calibrators and controllers; vibration monitoring systems and controls; analytical instrument; drilling power section; pressure and level sensors; and non-destructive testing equipment. The company was formerly known as Roper Industries, Inc. and changed its name to Roper Technologies, Inc. in April 2015. The company was incorporated in 1981 and is based in Sarasota, Florida.
Latest ROP
- iPipeline Named Finalist in ThinkAdvisor’s 2026 Luminaries Awards for AI Innovation & Impact
- DAT: Truckload rates rise in September as diesel tops $6 a gallon
- New Enterprise Adapter Offers a Supported PowerPlan Integration Between PowerPlan and Oracle® Fusion Cloud ERP
- Frontline Education to Preview New Vision for K–12 District Operations at AASPA 2026
- Frontline Education and AI for Education Win Two Tech & Learning Best for Back to School Awards
- SEC Form 4 filed by Roper Technologies Inc.
- New insider Dubey Abhijit claimed no ownership of stock in the company (SEC Form 3)
- U.S. Bank and DAT: Contract and spot truck freight rates diverge
- Roper Technologies Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Abhijit Dubey joins Roper Technologies Board of Directors
Latest TEM
- Tempus to Report Third Quarter 2026 Financial Results on November 2
- Ambry Genetics Announces GenomeNext™, a Whole Genome Sequencing Test Solution to Improve Diagnosis for Rare Diseases
- Tempus Announces Multi-Year Collaboration with Moderna and Merck
- Amendment: SEC Form S-4/A filed by Tempus AI Inc.
- Tempus Announces 13 Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2026
- CEO, Diagnostics Schoenherr Thomas Edward sold $873,885 worth of shares (10,281 units at $85.00) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 76,740 units (SEC Form 4)
- Tempus Receives FDA Clearance for its ECG-MR AI Product Designed to Identify Undiagnosed Mitral Regurgitation
- CEO and Chairman Lefkofsky Eric P sold $19,366,630 worth of shares (250,000 units at $77.47) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 144 filed by Tempus AI Inc.
- Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s RNA Foundation Model